ArticleGastroenterology report2015

The efficacy and safety profile of albumin administration for patients with cirrhosis at high risk of hepatorenal syndrome is dose dependent.

Yuliya Afinogenova et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.